What question did this study set out to answer?

This study examines disparities in antidiabetic medication use and adherence among Hispanic adults with type 2 diabetes mellitus.

June 7, 2026Diabetes

2042-P: Disparities in Diabetes Medication Use among Hispanic Adults with Type 2 Diabetes Mellitus

View Full Paper

Ask AI

Bookmark

This study examines disparities in antidiabetic medication use and adherence among Hispanic adults with type 2 diabetes mellitus.
Analyzed electronic health records from the University of California Data Warehouse between 2019 and 2023.
Included adults with T2DM and a baseline HbA1c ≥7% and follow-up HbA1c after 6 months.
Used paired t-tests to assess changes in HbA1c based on treatment patterns and adherence.
Hispanic patients had a higher baseline HbA1c (9.3%) compared to non-Hispanic patients (8.7%).
21.1% of Hispanic patients received no therapy compared to 22.3% of non-Hispanic patients; medication adherence was 82.2% for Hispanic patients versus 89.8% for non-Hispanic patients.
Adherent Hispanic patients saw a greater reduction in HbA1c (−0.9) compared to non-Hispanic patients (−0.7), p < 0.0001.

No takes yet. Share an insight, caveat, or question.

Analysis demonstrates ethnic differences in medication use and HbA1c levels in adults with diabetes, suggesting a need for targeted interventions.

FAN et al. (2026) studied this question.

View Full Paper

Ask AI

Bookmark

Analysis demonstrates ethnic differences in medication use and HbA1c levels in adults with diabetes, suggesting a need for targeted interventions.